Crossmark

Significance of busulfan administration route including therapeutic drug monitoring in the conditioning regimen of pediatric patients prior to hematopoietic stem cell transplantation

Crossref DOI link: https://doi.org/10.1007/s00432-025-06179-w

Published Online: 2025-04-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Hämmerle, Stephanie

Ernst, Jana

Steiner, Regula

Güngör, Tayfun

Milde, Till

Gruhn, Bernd
Funding

Funding for this research was provided by:

Universitätsklinikum Jena
License Information

Text and Data Mining valid from 2025-04-04

Version of Record valid from 2025-04-04
More Information

Article History

Received: 15 February 2025

Accepted: 20 March 2025

First Online: 4 April 2025

Declarations

:

: The authors declare that they have no conflict of interest.

: All procedures were in accordance with the ethical standards. The study has been approved by the Jena University Hospital Ethics Committee (2023–3158). Informed consent was obtained from all individual participants or the responsible persons included in the study.

Document is current

Any future updates will be listed below